Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 2881 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1SGLT -2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study
Vanessa C. Brunetti,Pauline Reynier,Laurent Azoulay,Oriana Hoi Yun Yu,Pierre Ernst,Robert W. Platt,Kristian B. Filion
Pharmacoepidemiology and Drug Safety.2021;30(6)740
[DOI]
2CuIIand AuIIIComplexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy
Nicoḷ Pettenuzzo,Leonardo Brustolin,Elisa Coltri,Alberto Gambalunga,Federica Chiara,Andrea Trevisan,Barbara Biondi,Chiara Nardon,Dolores Fregona
ChemMedChem.2019;14(12)1162
[DOI]
3CuIIand AuIIIComplexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy
Joanna Krajewska,Wojciech Krajewski,Tomasz Zatonski
ChemMedChem.2019;14(12)919
[DOI]
4Fundamentals about onset and progressive disease character of type 2 diabetes mellitus
Rob NM Weijers
World Journal of Diabetes.2020;11(5)165
[DOI]
5Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat
Chih-Chao Yang,Yen-Ta Chen,Christopher Glenn Wallace,Kuan-Hung Chen,Ben-Chung Cheng,Pei-Hsun Sung,Yi-Chen Li,Sheung-Fat Ko,Hsueh-Wen Chang,Hon-Kan Yip
Biomedicine & Pharmacotherapy.2019;109(5)658
[DOI]
6Pharmacological aspects of the safety of gliflozins
Jean-Luc Faillie
Pharmacological Research.2017;118(5)71
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal